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DIVERSITY
In recent decades, science and technology have had an 
increasing impact on society. This impact is beneficial when 
you think of increased health, increased mobility, increased 
safety (from natural disasters, for example). However, 
science and technology also produce new risks and vulner-
abilities; examples include the toxicity of new chemicals, 
risks of large technical system failure or ecological damage. 
New scientific and technological developments therefore 
often cause public reactions: positive hype, negative fear or 
debate. Examples range from food additives to GM food and 
the radiation risks of mobile phones. 
Scientific and technical developments are increasingly 
(though not always) accompanied by public reaction or 
debate. The virtual ban on GM foods is often cited to 
illustrate the damage that can be done by not taking public 
worries seriously enough. Current investments in public 
dialogue on nanotechnologies show how the Dutch 
government is trying to do better. The case of the radiation 
risks of mobile phone masts is an example of a technologi-
cal development that initially seemed good to society, but 
which later became cause for debate and even worries 
among public and experts. In these cases we see a clash 
between our evolving knowledge society, marked by exploit-
ing the benefits of science and technology, and our risk 
society, marked by coping with the risks and side-effects of 
science and technology.1 
Social science research is needed to better understand the 
interactions between science, technology and society; to 
chart the shifts in depicting our society positively as a 
knowledge society or negatively as a risk society; and to 
better deal with sudden changes in public appreciation 
from hype into fear or vice versa. Such social science 
research also helps design better interactions between a 
broad range of stakeholders, experts and members of the 
general public. 
The key message of this chapter is that there can be no 
viable innovation without its acceptance in society: science 
and technology only function when they are well en-
trenched in society. And for such adequate embedding of 
innovations in society, research into the social aspects of 
specific scientific and technical developments is necessary. 
With the insights of that research, we then can proactively 
design adequate forms of dialogue, public debate and 
interactive forms of development. All these elements should 
be part of the core business of PPPs that try to move the life 
sciences into the 2020s. 
This chapter thus presents three closely related messages:
1.		Research into the social aspects of life sciences, also in 
2020, is indispensable for a strong life sciences sector;
2.		Organized	interactions – participation, engagement, 
dialogue and education – with and between different 
stakeholders and civil society are necessary for a demo-
cratic and thereby sustainable development of the life 
sciences and technologies; 
3.		Good	governance of social issues surrounding life 
sciences innovation requires the facilitation of checks 
and balances between different types of knowledge, 
discourses and views. 
Together, these activities – research, interactions and good 
governance – are indispensable for the social entrenchment 
of life sciences innovations. Without such, innovations 
cannot be sustained.
IX  Social aspects
A. Introduction
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We	need	solid	information	and	good	education
To me, it is beyond a doubt that public acceptance of life sciences innovations is crucial to 
whether such innovations will actually be used and produced. What we should avoid at all 
times are unrealistic promises and expectations and we should use solid information to 
rigorously refute Frankenstein stories that in no way relate to what is really happening in the 
life sciences. The benefits of life sciences innovations can be high, alleviating pain and 
suffering, for example, in seriously ill populations. But one mouse with an ear on its back 
seems to have more impact than 100 serious articles. 
 
It cannot be repeated enough that scientists need to pay due attention to their communi-
cation with society. This includes communication with media, politicians and future 
teachers as these actively shape the different forms of knowledge and images that we find 
in society. And don’t forget the young generation!
Communication thus is not an additional task for the life sciences but should be an intrinsic 
part of it. Scientists have a responsibility to provide good information and to reflect on the 
social aspects of their work, even if this is complex and if it is uncertain what future results 
may yield. 
The social sciences and humanities, in turn, should critically assess what are the issues at 
stake in life sciences innovations. They should enable good communication about these 
issues and allow for well-informed and inclusive discussions and debates. Innovations only 
are viable when they become embedded in society. In that sense, there is still an entire 
world to win over.
Erica	Terpstra,	Chair	of	the	Dutch	Olympic	Committee	(NOC*NSF)	and	former	
Chair	of	the	Standing	Committee	on	genomics	in	the	Dutch	Parliament
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What	are	social	aspects?
Over the past decades, attention for the social aspects of 
newly emerging and converging sciences and technologies 
– such as genomics, nanotechnology, biotechnology, 
bio-nanotechnology and other innovative technologies – 
has become an almost natural component of science and 
technology development. 
What do we mean when we speak of social aspects of the life 
sciences? Asking this question to a random group of (life) 
scientists will generate an array of answers. Where one 
scientist will define it as a matter of public communication 
(the public does not completely understand what we do), another 
will mainly refer to ethical concerns (how far are we allowed 
to go in intervening in life?), or rather to legal, practical and/or 
organizational problems (do participants in biobanks also have 
the right to obtain research results, and how can this be 
arranged?). These answers are all relevant, to be sure, but 
they also reveal that the social aspects of the life sciences 
are diverse and multifaceted. 
Research into the social aspects of the life sciences is often 
called ELSA or ELSI research, which refers, respectively,  
to innovative technology’s Ethical, Legal and Social Aspects 
or its Ethical, Legal and Social Impact. ELSA research is 
performed by social scientists (technology scholars,  
sociologists, psychologists, communication experts, etc.), 
philosophers (ethicists, theologians), political scientists and 
legal experts. 
In this chapter, we will systematically use “ELSA” as 
shorthand for scientific study into the ethical, legal and 
social issues and the interrelated activities aimed at 
education, public debate and dialogue, and interactions 
between stakeholders and life scientists. ELSA thus includes 
both analyses and critical reflection (what is the issue,  
what is at stake) and activities to discuss and interact about 
issues with different parties.
ELSA typically includes:
n  The identification of (ethical, legal and social) issues; 
n  Interpretation and analyses of these issues; 
n  Organized interaction and dialogue with stakeholders 
(including publics); 
n  Interaction between policy, politics and professional 
practices; 
n  Development of new forms to organize the governance  
of ELSA issues; 
n  Evaluation of the design and development of the 
governance of ELSA issues. 
While this list may suggest there is a certain order to the 
activities, this is not necessarily always the case. Interac-
tions may lead to new research questions concerning a 
particular ethical, legal or social issue and vice versa. 
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B. Social aspects of the life sciences
Background	of	ELSI/ELSA	research
The introduction of the term ELSI is historically tied to the 
Human Genome Project (HUGO). During his installation as 
director of HUGO, James Watson, who in 1953 together with 
Francis Crick elucidated the structure of DNA, rather unex-
pectedly announced that the ethical and social aspects of this 
research required special attention and that 3-5% of the 
National Institutes of Health budget would be spent on social 
issues involved.2 Others followed the example of Watson, and 
the Human Genome Project invested generously in academic 
research into the social aspects of genetics and into educa-
tional projects that familiarized citizens with the pervasive 
presence of genetics in tomorrow’s world.
Interestingly, as a concept ELSI (or ELSA, as is more common in 
Europe) is used more and more to refer to social study of 
innovative technology in general, rather than being limited 
exclusively to genetics or genomics research.1,3,4
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In the next section we will further explore the aim, task and 
use of ELSA research. This section will continue with discuss-
ing what are the social issues concerning the life sciences.
The	interrelationships	of	science,	technology	and	
society
The application of new knowledge and technology has not 
only made our life more enjoyable, efficient, healthy or 
prosperous; it has also changed our habits and lifestyle, as 
well as our views and normative frames for judging the world. 
For instance, the development of the contraceptive pill has 
contributed to a new sexual morality; large-scale application 
of prenatal diagnostics has contributed to acceptance of 
abortion among certain groups; and the development of 
alternative sources of energy has raised our collective 
awareness of changes in climate and the environment. 
Does technology automatically steer our society in particu-
lar directions, including the individuals who are part of it? 
Things are slightly more complicated than that, because 
society has a major influence on technology development as 
well. Research priorities are partly triggered by questions 
about social issues and are realized in a process in which 
various parties – such as governments, social organizations 
and advisory bodies – act as representative of particular 
public interests. In the public domain, debate and dialogue 
take place that in part shape science and technology 
development. In many cases, public debate even functions 
as a major catalyst: it causes particular developments in 
research either to accelerate or to decelerate. While examples 
of deceleration – such as nuclear energy, GMOs and the 
sinking of the Brent Spar for example – are mostly well 
known, acceleration is also common. Developments in 
forensics research are a case in point, as will be shown in 
the next paragraph. Importantly, a catalyst itself does not 
change in the chemical process; it remains unaltered. The 
metaphor, then, does not apply fully: the nature of a public 
debate is altered of course as soon as its content changes.
In recent years, calls for tough policies against crime and 
delinquency have increasingly become common in public 
debates. In this context, DNA study is often presented as 
irrevocable proof (even if this is not always true). Cases that 
receive a lot of public attention and about which there is 
great public outcry and concern – such as the murder of 
Marianne Vaatstra in a village in the province of Gronin-
gen, in which the initial suspect, an asylum seeker from a 
nearby refugee center, proved to be innocent – have 
contributed to social support for expansion of criminal 
investigation methods. As a result of this case, the Nether-
lands became the first country where it was legally possible 
to determine the appearance of perpetrators – hair color, 
eye color, origin – on the basis of DNA material.5 Although 
the options for applying this method are technically still 
quite limited, its legal adoption has already stimulated more 
study of forensic techniques. Another example of acceler-
ated development is given by Steve Epstein in Impure 
Science.6 Epstein shows how in the 1990s, AIDS activists 
pushed for accelerated admission of AIDS medication in 
clinical trials, thus bringing about a change of regulation.
The abovementioned examples show how science and 
society mutually influence each other, or, as social scientists 
call it, co-construct each other: developments in science 
coincide with developments in society. This may imply that 
knowledge and technologies are developed less rapidly, for 
instance because their social consequences are unclear or 
because major parties in society reject a certain develop-
ment (for the time being). But the reverse is also possible: in 
some cases, social parties and social developments in fact 
call for accelerated deployment of knowledge or technology. 
Both the pace and direction of innovation may need to be 
fine tuned in order to be in line with the social conditions, 
expectations and opportunities involved. 
The concept of co-construction does not only provide an 
angle for understanding the dynamic relationship between 
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science and society; co-construction of science and society 
may also be actively shaped to enable a better handling of 
knowledge and innovation. This process of coordination 
between science and society is geared not so much towards 
creating a social base or public support; rather, it is aimed pri-
marily at creating alignment between specific social institu-
tions, conditions and expectations, on the one hand, and 
new technological possibilities and promises on the other. 
Social	issues	in	2020
How will the life sciences affect us in 2020? Science and 
technology increasingly are complex processes, incorporat-
ing both scientific and social trends. The transition towards 
a bio-based economy or poultry farming organized by 
genetic selection – to use two examples from this volume – 
requires a transformation of habits and lifestyle, the chain 
of production, and our attitudes towards energy, mobility 
and meat consumption. This raises a whole series of 
questions and it is unclear what will emerge as the main 
social issues. This has become less and less easy to foresee: 
n  It is characteristic of recent discussions that topics are 
complex in a scientific-technical sense. Example: the 
convergence between biotechnology, nanotechnology, informa-
tion technology and new technology based in cognitive 
sciences. This brings together expertise and knowledge from 
different paradigms and leads to new approaches and bodies 
of knowledge 
n  Social issues increasingly are (connected to) technical 
and scientific issues. Example: the issue of “ownership”. 
This is connected to questions of open-source and intellectual 
property rights, biobanks and the use of bodily material, 
indigenous species and bio-piracy, the use of DNA in court 
cases and scientific publishing 
n  In public discussions, one increasingly is looking for 
methods that avoid black-and-white contradictions and 
possible deadlocks. Undoubtedly this also leads to the 
clouding of political discussion and to results and choices 
that are not very transparent. Example: the discussions on 
the widening of PIGD and the freezing of egg cells. These 
discussions are not just geared towards either an outspoken 
“pro” or “con”, but rather towards the (prior) conditions and 
circumstances under which these developments would be 
acceptable 
n  In a normative sense, there are multiple voices. It is hard 
to predict in advance which positions parties will take. 
On top of this, it is unclear what role religion will play in 
future issues and debates 
n  Social issues do not necessarily always affect the public 
directly. Example: the discussion on breeders’ rights and 
patent rights. This discussion is about access to genetic 
material and whether it impedes innovation, and this pertains 
to the business sector, government and universities alike
n  Scientific expertise does not always equal authority, since 
social issues cannot be reduced to techno-science. For 
one, scientists do not always agree with each other; nor 
do we expect them to agree with each other at all times. 
Example: discussions on climate change or biofuels and the 
question of whether these are an effective source of alternative 
energy. Differences in scientific insights increasingly have 
become publicly visible and as such have enriched many 
a debate. However, this trend also shows the uncertainty 
and diverse character associated with science and 
technology development 
While it is difficult – if not impossible – to predict what the 
social issues will be in 2020, it is possible to say something 
about the nature of these issues. They will be complex, 
include multiple questions, address not just the general 
public (but also industry, scientists and governments), resist 
simple solutions and mobilize ad-hoc coalitions and 
spokespersons. As the example of ownership illustrates, 
issues are not necessary life sciences topics, but are typically 
issues that require knowledge and understanding of the life 
sciences. This is exactly what ELSA has to offer.
Dealing with social issues in a sensible way is crucial for the 
social entrenchment of life sciences technologies. ELSA thus 
does not aim to avoid issues or prevent them from emerg-
ing, but rather aims to allow the right issues to emerge, and 
to use this to improve the quality of innovations and their 
embedding in society. 
DIVERSITY
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C. The contribution of ELSA
ELSA	research	
The task of ELSA research is twofold. First, it aims to 
contribute to the theoretical development and understand-
ing of the relationship between (life) sciences and society by 
asking fundamental questions about this relationship. 
Second, ELSA research aims to shape and facilitate the 
relationship between (life) science and society by organiz-
ing different forms of interactions and interventions in 
order to anticipate (emerging) social issues connected to 
scientific developments. These tasks relate to one another in 
a productive tension (between critical analyses and 
interactive design). ELSA research thus can be said to 
uncover the different and multiple meanings, expectations, 
forms of knowledge, discourses, opinions and interests 
related to science and technology development, and, if 
possible, to confront them with each other. The first part of 
this task focuses mainly on (fundamental) research; the 
second requires interaction and intervention with different 
parties. In the following, we will first explore what we mean 
by different and multifaceted expectations, framings and 
discourses and how to anticipate future impacts or effects of 
science and technology. In the paragraph that follows, we 
will discuss the interactive design of ELSA research. 
Multifaceted	developments	considered	more	closely	
The starting point of ELSA research is the multifaceted 
character of developments in the life sciences and how they 
are addressed. As we will show, the issues we are faced with, 
as well as the solutions offered by the life sciences, are more 
ambiguous than commonly represented – also by the 
authors of this book. This is hardly surprising. The life 
sciences and social sciences or humanities are different 
disciplines that have different tasks. We will return to this 
point later in this chapter, when we discuss the organiza-
tion and governance of ELSA.
Developments in the life sciences, as described in this 
volume, will influence our life more and more. In 2020, the 
life sciences will provide a substantial contribution to major 
and urgent questions, problems and opportunities in the 
fields of health, the climate, energy, food distribution and 
the environment. This book sketches the contours of a 
world in which energy is no longer derived from fossil fuels, 
our food pattern will come with fewer animal proteins and 
be more tailored to our body’s specific needs, and the health 
of an ageing population is monitored at regular intervals. In 
other contexts – advisory reports, corporate websites, 
brochures, presentations, documentaries, articles newspa-
pers and weeklies – we find the same promises and we are 
told that the life sciences address the most pressing and 
urgent social issues. 
There are few people who will deny that the climate, 
energy, food issues and health pose important future 
challenges and are therefore worthy of our attention. 
However, the issue of how these subjects ought to be 
addressed and which solutions or contributions are needed 
is much harder to answer. In many of these cases there is no 
consensus. Urgent social problems are linked to quite 
diverse solutions. Moreover, in this discussion, different 
figures, facts and data tend to be used as evidence. We 
illustrate this point with the example of the global food 
problem in the box: “The global food problem as an 
example of shared goals & multiple evidence and solutions”.
The parties that we describe in the box – the Minister of 
Agriculture, Monsanto, plant researchers and NGOs such as 
Greenpeace – agree that the development of new agricul-
tural knowledge and technologies cannot and should not be 
limited to national borders. The Netherlands is co-responsi-
ble for world food distribution. How this should be arranged 
by government, science, industry and social organizations is 
less evident, however. 
For example, parties are fighting over whether GMOs offer 
the right solution and which risks or socio-economic effects 
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The	global	food	problem	as	an	example	of	shared	
goals	&	multiple	evidence	and	solutions	
In discussions about the global food problem it is usually 
assumed that in 2050 the world population will have climbed 
from 6.8 to 9 billion people. This growth perspective can be 
heard in many discussions about the life sciences, often 
represented by the same figures yet from a different angle. 
Recently the Dutch Minister of Agriculture argued for a new 
evaluative frame for GMOs during a meeting in The Hague. It 
should focus not so much on the safety of GMOs, but on the 
question of whether and how GMOs may contribute to 
sustainable agriculture. A major element of sustainable 
agriculture, the Minister claimed, is its contribution to solving 
the global food problem. By making use of GMOs, acreage 
can be used more efficiently, the certainty of harvests can be 
raised and it becomes possible to use land – such as with 
saline or dry soils – where before crops did not grow. To	be	
able	to	feed	all	9	billion	mouths	in	the	future,	the	
Minister	argued,	a	new	evaluative	frame	for	GMOs	is	
necessary.
Science and technology, including possibly GMOs, play a 
major role in the chapter on agricultural life sciences in this 
book. Here too arguments around efficient use, harvest 
certainty and new acreage come into play. However, its 
authors underscore the significance of investments in 
research, rather than a new evaluative frame. To	feed	all	9	
billion	mouths	in	the	future,	according	to	the	authors	
of	the	agricultural	life	sciences	vision	of	this	book,	
research	is	inevitable.
In 1997, Monsanto decided to sell its chemical division and 
focus exclusively on the life sciences. The then director 
Shapiro explained this step as follows: “We create a new kind 
of company that concentrates on meeting the worldwide 
need for food and health” (cited from de Vriend and 
Schenkelaar, p. 25).7 In recent discussions on the question of 
whether patent law would annul breeders’ rights through a 
backdoor, a situation from which large companies seem to 
benefit for the time being, Monsanto stresses that it has to 
earn back returns on its investments through patents. Only	
in	this	way,	according	to	the	spokespersons	of	Mon-
santo	and	other	large	companies,	it	will	be	possible	in	
2050	to	feed	9	billion	mouths. 
NGOs such as Greenpeace and Solidaridad are probably no 
less concerned about the world food problem than Verburg 
or the scientists at Monsanto. However, in their plea GMOs are 
not automatically the solution to the global food problem. 
“Food security will not be achieved by technical fixes, like 
genetic engineering (GE). People who need to eat need 
access to land on which to grow food or money with which to 
buy food. Technological ‘solutions’ like GE mask the real 
social, political, economic and environmental problems 
responsible for hunger” (www.greenpeace.nl). Poverty, the 
lack of acreage for poor farmers, unfair trade regimes and 
disproportionate attention for industrial agriculture are much 
more important causes. Small-scale	agriculture	and	
attention	for	these	problems	contribute	to	the	
possibility	in	2050	of	feeding	9	billion	mouths. 
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are involved. Moreover, they use the food distribution issue 
to argue for other things: a new evaluative frame (the 
Minister), patent rights (Monsanto), research funds (scien-
tists), biological agriculture and assistance to small farmers 
in developing countries (NGOs). 
When we look at the applications of the life sciences, we 
also find profound differences in how these are framed and 
valued. Life sciences innovations may lead to pressing 
questions about their use and value. Which innovation 
should be applied for what purpose? It is impossible in our 
pluralist society to give a single answer to this question. It 
will be no surprise that here, too, we are dealing with a 
wide array of opinions, views and perspectives. These 
partly involve ethical questions. For instance, if one party 
considers the use of embryos for stem cell research a 
chance to cure people who suffer from serious, untreatable 
disorders such as Parkinson’s, others will dismiss such a 
proposal as an outright violation of the “right to life”. Next 
to ethical or moral differences, there are also differences of 
interpretation that flow from a difference in focus or 
perspective. For example, biological meat production is 
regarded by many as an important contribution to sustain-
able animal husbandry; others stress that biological 
production requires more feed and is generally less 
efficient. Whether or not something involves a sustainable 
solution depends on the comparative basis involved 
(sustainable as relative to what?).
What should we conclude from all of this? Although the 
same notions, concepts and goals are frequently used, such 
as environmental problems, climate change, health benefits 
and sustainability, it is evident that they do not always have 
the same meaning. These terms and concepts are seemingly 
clear and unambiguous, but they actually disguise the 
pluralist meanings and stakes we encounter in everyday 
practices. Meanings, rather than being objective or neutral, 
are always moral and political.
INTERMEDIATE	CONCLUSION			The	seemingly	
transparent	concepts	and	goals	used	in	discussions	
about	the	life	sciences	disguise	the	plurality	of	
meanings	involved.	ELSA	research	aims	to	uncover	
this	plurality.
Anticipating	impacts	or	effects	of	the	life	sciences	and	
technologies
Science and technologies are not merely used to solve or 
address social issues and concerns; they contribute to the 
emergence of new questions, issues and problems. We are 
living, according to Ulrich Beck, in a “risk society”.8 The 
risks that pose a challenge to modern societies are no longer 
determined by fate – such as natural disasters like storms, 
droughts and floods – but rather originate in the application 
of manmade science and technologies. The paradox of 
today’s world is that it is faced with “mega-dangers or 
hazards that are on the one hand created by society itself, 
but on the other are neither attributable nor accountable 
nor even manageable within society” (cited from Strydom, 
p. 59).9 It is also true for the life sciences that the knowledge 
and techniques we deploy in the next ten or twenty years to 
solve social issues and problems also result in a number of 
unknown and unplanned consequences. 
There is much speculation as to the future social, ethical 
and legal effects and impact of developments in the life 
sciences. At an early stage, ELSA researchers, but also 
novelists and the media, try to anticipate the unknown and 
unplanned consequences of science and technology 
development: who is affected by new developments, who 
benefits from them, but also who or what will suffer 
possible adverse effects or even harm? The objective of early 
anticipation of social consequences of developments that 
have not yet crystallized is to push developments in a 
socially desirable direction.10,11,12 ELSA research, we may say, 
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functions as an early warning, indicating what social issues 
may become relevant or contested in the future. 
 
One way to address future consequences of life sciences 
developments is through “future images”. Through scenario 
studies, foresight exercises, risk analyses, Delphi-methods 
and real-time technology assessment, scientists – often 
together with stakeholders – try to reflect on technological 
futures. This goes beyond extrapolation of current develop-
ments and is actively aimed at desirable futures. Interesting 
examples can be found in the field of nanoscience. Also in 
the life sciences, as developments will become more 
complex and uncertain in terms of applications and effects, 
such exercises will be increasingly needed. 
Promises and expectations, if broadly accepted and 
subscribed to, push the process of science and technology 
development into specific directions.13 This is true both for 
the promises of life scientists as for the future images 
created by ELSA researchers. Promises and expectations 
thus guide future actions and therefore need to be relevant 
and somewhat realistic. However, sometimes promises are 
not realistic at all and this too may serve a purpose. This 
may be a warning, an attempt to frighten people, or an 
intervention to make developments go into a different 
direction. A critical analysis of promises, projections and 
expectations is part of the ELSA agenda. What do promises 
do? Can we assess the quality of a particular promise? 
Which promises does ELSA research produce? How do 
scientists themselves relate to specific promises? 
Setting	the	agenda	
Through the anticipation of unknown social consequences, 
ELSA aims to identify issues and problems that need to be 
addressed to improve the social entrenchment of the life 
sciences and technologies. ELSA scholars, from time to time, 
put issues on the agenda before others have done so and before 
these have become an issue in the public domain. But, unlike 
what life scientists sometimes suggest, ELSA is not capable of 
making an issue public if this is not supported or picked up by 
others. ELSA can only help put issues on the agenda. 
When ELSA identifies problems that should be addressed – 
as in the case of nanotechnology14,15,16,17 – this is something 
to heed. What are the risks associated with new technolo-
gies? Which social sensitivities, concerns and worries 
perhaps play a role at a later stage? Who is concerned about 
what issue? Where may we expect resistance or support? In 
short, the work of ELSA researchers establishes which 
problems, issues and questions may come into play in the 
future. Naming them provides insight into future issues and 
possible problems and enables their anticipation. 
ELSA	activities
We have shown that promises and statements around the 
developments of the life sciences are hardly neutral or 
unambiguous; rather, they imply a large number of 
assumptions, choices and perspectives. We have argued that 
one of the tasks of ELSA researchers is to reveal these 
differences and to confront, contrast or bring them into line 
with each other through interactions and interventions. 
The aim of these interactions is to help shape the social 
entrenchment of the life sciences. This, then, is done by 
organizing a confrontation between the different types of 
knowledge and discourses that are brought to bear on the 
risks and uncertainties concerning the life sciences. ELSA 
research, we might say, aims to facilitate the right “checks 
and balances”. 
Facilitation	of	checks	and	balances	
The concept of “checks and balances” originated in 18th 
century political theory and practice. Applied to political 
governance in constitutions of all democratic regimes the 
world over, it is still a vital method to keep single individu-
als or (interest) groups from becoming too powerful. 
Organizing checks and balances is based on a combination 
of functional separation and sharing of powers. Usually, 
governance powers are formally divided between three 
branches or entities of government: the executive, the 
legislative and the judiciary. Equally important in this 
doctrine of trias politica are mechanisms of formal and 
informal power sharing. Essentially, each branch of govern-
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ment has some control over the actions of the other two 
branches. In this way, the separate branches are empowered 
to prevent actions by the other branches, but induced to 
share power at the same time. 
Thus, the checks attribute to each power the right and actual 
possibility to monitor and evaluate the decisions and 
actions by the other branches. We encounter this idea in 
modern governance often as the transparency requirement; 
or, in legal terms, the right to be informed. The balances 
part confers on each branch or entity the resources, 
authority and powers to limit the resources, authority and 
powers of the others. Jointly, these checks and balances 
define a control mechanism that guards against abuse of 
power. For example, the executive (government, cabinet) 
has the right to propose policy or bills and direct their 
implementation; but the legislative (parliament and other 
representative bodies) has the right to approve, reject or 
amend such proposals, the right to give or withhold 
funding, and to formally evaluate modes and results of 
policy implementation; the judiciary may declare executive 
(and sometimes even parliamentary) decisions as unconsti-
tutional or as contravening administrative laws and 
principles of good governance.
Applied to the field of the life sciences, ELSA research 
facilitates the right checks and balances between other 
players. ELSA research and other scholarly activities 
involve not just inquiry into the ethical, legal and social 
aspects of distinct innovations and technologies. Moreo-
ver, and unique to the ELSA perspective, it envisages and 
conceptualizes the entire governance of an innovation 
system. By critically examining the relative influences  
on this system of science, business and government and 
posting early warning signs on certain phenomena, 
events, trends and developments, the ELSA perspective 
contributes to and facilitates good governance of life 
sciences innovation by enabling the other players to 
achieve a proper set of checks and balances. Of course, as  
a method of “empowering”, ELSA research and scholarship 
can never achieve this alone; it clearly depends on 
dissemination and reception of its messages through 
fruitful boundary arrangements with the other more 
powerful and resource-rich players in the field – especially 
business and government. Yet, good governance is not just 
about powering and preventing abuse of power. It is also a 
matter of creative puzzling. 
INTERMEDIATE	CONCLUSION			The	unique	
contribution	of	ELSA	research	and	scholarship	is	in	
the	uncertain	part	of	the	good	governance	of	
innovation:	its	(early)	warning	signs	provide	creative	
confrontations	between	valuable	perspectives	on	
life	sciences	innovation	that	will	increase	these	
innovations’	sustainability.
The role of ELSA within the life sciences is facilitation of the 
proper checks and balances. Parties are thus actively involved 
in various ways. They are 
n 	informed of developments in the life sciences;
n 	consulted on knowledge, views, fears and expectations; 
n 	mobilized to participate in discussion, dialogue and 
decision-making on the application of new knowledge 
and technology. 
Facilitation of the proper checks and balances offers no 
guarantee for the solution of problems or an effective 
tackling of issues. ELSA research stimulates the creative 
confrontation of different perspectives, for example in 
debate and dialogue, but it can only do so when others join 
in as well. Creative confrontations may concern particular 
segments of the public (such as patients, consumers, 
parents, citizens or students), stakeholders (industry, NGOs, 
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citizens, professionals, retail), scientists (the life sciences as 
well as social sciences and humanities) as well as those  
from policy and politics (administrators, finance experts, 
legislators, decision makers or members of parliament). 
Diverse groups contribute variously to the articulation  
of a multiplicity of ideas, expectations, notions and goals 
around the life sciences. While we often make use of 
simplified distinctions, such as that of experts, policymak-
ers and citizens, these categories in fact refer to a wide 
diversity of groups and individuals. In the following, we 
focus in particular on interactions with the public and  
with policy/politics. 
Interactions	with	the	public	
The general public, ranging from citizens to workers in 
laboratories, plays a major role in the development of 
science and technology. People are confronted with the 
applications, and hence the risks, unplanned effects and 
benefits of life sciences developments. Furthermore, the 
general public in democratic societies is entitled to join  
in decisions on public matters. In the context of the life 
sciences, this means that citizens have indirect decision 
power (through elections) or direct decision power (as 
consumer, patient or citizen). The public forms an impor-
tant check or counterbalance: “Expertise is constituted 
within institutions, and powerful institutions can perpetu-
ate unjust and unfounded ways of looking at the world 
unless they are continually put before the gaze of layper-
sons who will declare when the emperor has no clothes” 
(cited from Jasanoff, p. 397-98).18 
It is often argued that, to be able to join decisions on public 
matters, it is essential that citizens have access to informa-
tion, (various forms of) knowledge and expertise. Both ELSA 
researchers and life scientists have an obligation to provide 
such information and, related to this, education and 
communication. Various different examples are available to 
achieve this, such as:
n  Education at schools (competitions, websites, workshops, 
internships and site-visits);
n  Training (young) scientists to communicate (even better) 
with various public about their field;
n  Public meetings and discussions with scientific experts 
and other stakeholders;
n  Entertainment, festivals and exhibitions;
n Films, books and documentaries.
The availability of information and education is a prerequi-
site for the public to understand and evaluate developments 
in the life sciences. However, providing information and 
education about life sciences developments is not a goal in 
itself. It aims to empower citizens to assess and counterbal-
ance different forms of expertise. Experts and the knowl-
edge and information that they provide – life scientists and 
ELSA researchers alike – have their own biases. “Public 
engagement is needed in order to test and contest the 
framing of the issues that experts are asked to resolve. 
Without such critical supervision, experts have often found 
themselves offering irrelevant advice on wrong or misguid-
ed questions” (cited from Jasanoff, p. 397-98).18 
Public engagement or public participation exercises may take 
different forms at various levels. The key to public engage-
ment is that the public is actively involved in some issue. 
This applies to more than just an exchange of ideas and 
points of view. In many cases it calls for the organization of 
genuine dialogue. The results may vary: organized interac-
tions may contribute to the exploration of difference and the 
formulation of possible directions for solutions. Interactions 
may be aimed at a) shared study of issues; b) exploring 
differences in views and/or perspectives; or c) formulation of 
shared frames, rules, solutions or visions. In some cases 
(consensus conferences, stakeholder meetings) participants 
are explicitly asked to develop a shared point of view. In 
other cases the conclusions may well reflect the various 
input, but a single conclusion or consensus is not pursued.
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More important than the actual organization of public 
engagement activities is the framing or the context of 
engagement activities. The facilitation of the right checks 
and balances primarily asks for an analysis of who partici-
pates, who determines the agenda and what is the aim of 
the event.
Framing	the	debate	
Social issues concerning the life sciences may affect the 
public, industry, scientific experts or government regulators, 
to name just a few parties. How these issues are addressed 
and who is allowed to join the debate cannot be derived 
automatically from an issue itself. Who may join a debate 
about some issue and – perhaps even more importantly – 
who decides on its topics are part of the dynamic and 
debate around technological innovation. A case in point is 
the debate on Food and Genes (Eten en Genen) that took 
place in 2002. This debate, organized by the Terlouw 
Commission, was criticized by a coalition of the Dutch 
branch of Greenpeace and 14 other Dutch NGOs. In a press 
release they claimed that they very much welcomed public 
debate, but that it should be based on an open agenda. The 
debate’s main goal was to clarify under which conditions 
the application of modern gene technology in food 
production would be acceptable to society. According to 
Greenpeace and the other NGOs, this was too limited a 
question: “The fundamental question of whether gene 
technology is desirable and necessary at all does not seem  
at issue. We are only allowed to talk about how it is to be 
applied” (cited from de Wilde et al, p. 66).19 At a recent 
meeting in The Hague, organized by the Dutch Minister  
of Agriculture, a discussion erupted on the 2002 debate’s 
agenda. In her opening speech, the Minister indicated  
that as far as she was concerned the question “do we want 
GMOs?” was no longer relevant. In feed, cotton and other 
products, she argued, so many GMOs are used already that 
there is simply no way back anymore (NRC Handelsblad, 
June 10, 2009). Reactions from the audience and also in  
the various workshops revealed that many people disagreed. 
Attempts to put this on the political agenda were to no 
avail, however.
The question of who or what sets the agenda for public 
debate is not just limited to the debate’s topic. Part of this 
question is also which arguments in the debate are 
considered valid. Emotions, for example, tend to be pushed 
aside as unfounded, not objective (hence, subjective) and 
therefore “invalid”.20 Thus it is ignored that precisely 
emotions may have a major effect. The British minister 
who during the BSE crisis offered his daughter a hamburger 
in front of the TV cameras to prove that eating beef was 
not a risk has become legendary. It led to major public and 
even media distrust. What this incidence showed is that 
the public, in these cases, is always right. The public uses 
different forms of evidence to establish whether British 
beef is safe or not. It is the effect of this process that matters 
(to British industry and farmers for example). Emotions 
have a large influence on social perception, acceptance  
and therefore also the uptake of new developments. 
Finally, the stakes of the debate are important as well: what, 
exactly, is the purpose of articulating views in the context 
of a debate? It should be clear from the start which interests 
are at issue. An example is the assignment of the recently 
established Public Dialogue Nanotechnology Commission. In its 
assignment letter to the Commission, the Dutch Minister of 
Economic Affairs writes that the Commission should make 
clear to the participants that they ought not to expect the 
government to “follow up on all outcomes”. The Cabinet, 
the Minister points out, has the responsibility to weigh the 
issues on its own, even if it will also “deal very carefully 
with the outcomes of the public dialogue”.21 That the 
government does not follow up on all suggestions from 
citizens seems obvious. Conversely, the meaning of 
“dealing very carefully with” leaves ample room for 
interpretation or implementation. 
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INTERMEDIATE	CONCLUSION			To	allow	for	the	
richest	possible	review	of	the	risks,	benefits	and	
implications	of	new	technologies,	the	following	
questions	are	important:
n				Who	has	the	opportunity	to	join	the	discussion?	
n				Who	has	a	say	about	the	concerns	addressed?	
n				Which	arguments	are	considered	to	be	valid?	
Which	arguments	are	kept	outside	of	the	
discussion	(or	should	have	to	be	kept	outside		
of	it)?	
n				What	is	the	purpose	of	the	discussion	and	thus	
what	is	at	stake?
Policy	interactions	
A major critique of the American ELSI program of the 1990s 
is that it mainly generated academic output, but that the 
program has had little influence on policies. According to 
Michael Yesley, who for years was responsible for part of the 
ELSI program, it was used from the start “to avoid establish-
ing an independent advisory commission, selecting topics 
of ethics research that will facilitate rather than challenge 
the advance of genetic technology, and spending ELSI funds 
on promotion in the guise of education” (cited from Yesley, 
p. 4).22 The ELSI program, Yesley argues, was uncommissioned 
and it was also unclear who specifically was awaiting its 
results. It served as a pretext to be able to say that attention 
was given to the social aspects involved. 
Others agree with Yesley that the ELSI program has had 
little impact.2,18 However, the question is whether Yesley is 
right when he points to the “uncommissioned nature” as 
the main cause for the lack of impact of the ELSI research. 
Another possible cause for this shortcoming is that ELSA 
researchers have poorly succeeded, if at all, in linking up 
with decision makers. 
Scientists and decision makers, according to Lomas,23 often 
have a distorted image of each other and insufficiently 
recognize that both are part of an intricate but shared 
context. Implicitly, they confirm the image they have of 
each other: scientists deal with facts and truth, policymak-
ers with values and power.24,25 Scientists expect that decision 
making takes place in a specific setting and at a certain 
point in time. Likewise, decision makers expect from 
scientists that their results are ready available when they 
need them: “it is like two people completing a jig-saw 
puzzle, each with half the pieces but each working in a 
separate room” (cited from Lomas).23 In practice, policy as 
well as research are pragmatic and context-bound. Both 
research and decision making are heterogeneous, complex 
and often take up much time.
More attention for what in the Netherlands we awkwardly 
refer to as “knowledge valorization” might increase the 
impact of ELSA research. An important aspect of the 
valorization of knowledge is early involvement of decision 
makers in both the overall process and the results of the 
research.23,26 Experience with technology assessment (TA) 
underscores that this is no simple task. This experience 
“show(s) that just publishing the results of these quantita-
tive and qualitative studies within academic journals will 
not lead to a big impact in the real world. To achieve that, 
the results need to be purposefully translated and commu-
nicated towards, for example, the policy arena or a wider 
public. Moreover, one needs to build personal connections 
with these different worlds to have an impact on these 
worlds” (cited from van Est).4
INTERMEDIATE	CONCLUSION			The	relationship	
between	scientists	and	policymakers	cannot	be	
shaped	in	an	ad-hoc	fashion.	It	requires	intensive	
mutual	exposure	and	interaction	between		
scientists	and	decision	makers.	This	exposure		
is	needed	for	the	actual	use	of	research	results		
in	policy.
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INTERMEDIATE	CONCLUSION			To	make	a	genuine	
contribution	to	the	life	sciences,	substantial	
research	and	public	communication	around	the	
social	aspects	of	the	life	sciences	are	necessary.	
Internationally,	3-5%	of	the	life	sciences’	total	
budget	is	considered	standard	for	ELSA.
Attention for the social aspects of innovative knowledge and 
technology is hardly new. This type of research has been 
performed since the 1970s from various angles, including 
bioethics, technology assessment (TA) and science and 
technology studies.27 From the start of this century, universi-
ties, aside from doing fundamental research, have paid 
increasingly more attention to the governance of new, 
innovative and converging technologies and the question of 
how the expectations of the market, government, civil society 
and science can be aligned. This is what, in this chapter, we 
have called the facilitation of the right checks and balances. 
The need for ELSA research and other scholarly activities that 
contribute to the good governance of new, innovative and 
converging technologies is not restricted to PPPs. These are 
only one place or setting where ELSA matters. While it can be 
argued that there are social issues that are perhaps pecifically 
relevant for PPPs, such as the analysis of bold promises to 
solve issues that worldwide are seen as global problems, these 
social issues, however, are not restricted to PPPs. The 
questions and issues that we have identified in this chapter 
are related to life sciences development and innovation in a 
broad sense. As we have shown, technology and society 
co-construct one another: technology, by implication, is 
socio-technology. 
For technology to become embedded in society, both 
technical and social expertise are necessary. These are only 
partly separated domains. ELSA researchers have to be very 
knowledgeable about the technologies they study while life 
scientists, either through experience or interest, are knowl-
edgeable about social issues. However, disciplines have 
different tasks. Scientists consider it their task to develop 
science and technology that contribute to the solutions of 
concrete social problems or issues. ELSA researchers and 
scholars also contribute to solving or coping with concrete 
social problems, but do so by questioning the (anticipated) 
effects of science and technology development. There is, 
then, a clear distribution of tasks between the life or natural 
sciences and the social sciences or humanities. Both bring 
different competencies, but have mutual interests and togeth-
er their skills are complementary.28 It is only together that 
these disciplines are able to improve the embedding of 
technological innovation.
Today, ELSA research of the life sciences is organized and 
funded in different ways, via single projects of individual 
research groups, small programs funded by NWO or the EU or 
sizable programs that are part of a PPP. ELSA research around 
genomics is, in a number of respects, the absolute priority. 
ELSA genomics is well funded, well coordinated, is visible in 
many contexts and it has led to a consolidated program. 
Within NGI, the social aspects of genomics are explored by 
the Centre for Society and Genomics (CSG) and the Genom-
ics Centres of CMSB, Kluyver, CGC and CBSG. In the current 
round of subsidies for NGI (2008-2013), EUR 25 million have 
been earmarked for the social aspects of genomics. While 
other programs, such as the Leading Technology Institutes 
(TTIs), also pay attention to social aspects, they do so at a 
much smaller level and in a less coordinated fashion. 
ELSA research of the life sciences requires coordination and 
a substantial investment. This will enable programs that 
consolidate different questions and approaches, are visible 
to life scientists, industry, politics and society and have the 
ability to have a substantial impact on the social entrench-
ment of the life sciences.
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The need for a coordinated effort and a substantial budget 
does not necessarily imply that ELSA research should be 
organized in one single project or location. Rather, we 
advocate a pluralist approach. Characteristic of the way in 
which present and future societies deal with science and 
technology development is the existence of different forms 
of knowledge, norms, values, ideas and expectations. This is 
no less true for ELSA itself. ELSA research, the scholarly 
activities of ELSA and the institutions involved in this work 
are multifaceted: ELSA brings together different disciplines, 
views, approaches, experiences and interests. This pluralism 
is enriching and should not be reduced to a single type of 
organization. Different forms are needed: 
1.		Open	calls	
  Open calls, such as the recently completed NWO 
program on “societal aspects of genomics”, enable 
research that poses a range of questions and makes use of 
a variety of methods, approaches and themes. More 
importantly, open calls allow researchers to ask both 
fundamental questions and to use methods or approach-
es that are innovative, experimental and/or – theoreti-
cally or methodologically – “daring”. 
2.	Commissioned	programs
  Commissioned programs are coordinated efforts  
characterized by producing focus and mass and  
providing a context in which specific questions can  
be addressed or where questions can be addressed in a 
specific way. With respect to PPPs, commissioned and 
coordinated programs can be either embedded in a PPP 
or be realized in independent programs with a critical 
distance from PPPs: 
	 2.a	Embedded	programs
  PPPs, as defined in this book, are collaborative projects in 
which partners from industry, government and universi-
ties work together on equal footing. The aim of PPPs, as 
we have seen, is to produce innovations that realize 
social and economic value. PPPs themselves have a 
responsibility to deal with the social aspects of their 
work. This may concern several things, such as the 
anticipation of and reflection on social issues and 
communication with the public, but also the public 
legitimating of PPPs. Since PPPs are set up with a majority 
of public funds, they are publically accountable for what 
they do. ELSA research may need to be embedded within 
PPPs as the place where mutual learning between ELSA 
research and the life sciences takes place. 
	 2.b	Independent	programs
  It is also important to acknowledge the critical function of 
ELSA research. Facilitating the proper checks and balances 
calls for a critical attitude with respect to, for example, the 
vested interests, the hegemony of scientific knowledge and 
the parties playing a role in creating innovations. If we 
take serious the assignment of ELSA research to address 
and confront the many different types of knowledge, 
promises and discourses brought to bear on the risks and 
uncertainties surrounding the introduction of life 
sciences, research should also be independent of PPPs. This 
does not eliminate the possibility of collaboration. 
However, it points to the necessity to have a part of ELSA 
research that is independently organized and funded. For 
this type of research, matching with industry is problem-
atic, as the governance of ELSA issues in these settings 
requires critical and independent analyses of the types of 
knowledge, discourses, parties and institutions of all 
stakeholders, including those partners of PPPs. 
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CONCLUSION			ELSA	research	and	scholarly	
activities	demand	different	modes	of	organization,	
both	embedded	in	and	independent	of	PPPs.	In	case	
of	the	latter,	matching	is	not	a	feasible	option.
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Samenvatting van de hoofdaanbevelingen
Dit is het tijdperk van de life sciences. Zij helpen ons  
maatschappelijke uitdagingen het hoofd te bieden in  
gezondheidszorg, voedsel- en energievoorziening en milieu. 
Ook werken zij als een motor voor onze kenniseconomie. 
Nederland heeft een unieke uitgangspositie in de life sciences. 
Ons wetenschappelijk onderzoek behoort tot de top drie in  
de wereld en Nederland heeft in voeding, gezondheid, 
agricultuur en chemie & energie sterke industriesectoren  
die de belofte van de life sciences kunnen inlossen.
Desondanks blijkt het moeilijk onze sterke kennisbasis te 
vertalen naar nieuwe producten, processen en diensten  
en die te leveren aan de maatschappij. In antwoord op  
deze uitdaging hebben academici, industrie en de overheid 
recentelijk op grote schaal de krachten gebundeld in pre-
competitieve onderzoeksamenwerking. Nu is het tijd om  
door te pakken en deze investering te laten renderen.
Vele vertegenwoordigers uit het life sciences veld zijn 
samengekomen om Partners in the Polder te schrijven. Het 
boek beschrijft de belofte van de life sciences en hoe Neder-
land deze belofte kan inwilligen, met bijzondere aandacht 
voor de rol van publiek-private partnerschappen (PPPs). 
Partners in the Polder kijkt naar hoe academici en industrie 
samenkomen om de kennisbasis te vertalen naar toepas-
singen: het ontstaan van PPPs, hun bedoeling en vooruit-
zichten, sterkten en zwakten, successen en mislukkingen.
Partners in the Polder komt tot drie hoofdaanbevelingen die 
breed gedragen worden door het veld en voortkomen uit de 
ervaring en deskundigheid van wetenschappers, onderzoek-
ers, zakenlieden en beleidsmakers uit alle hoeken van de  
life sciences en uit studies en publicaties van industrie- 
organisaties, de OECD, het Innovatieplatform en vele 
anderen. De auteurs hopen dat deze samenvatting de 
interesse van de lezer wekt in het boek zelf. Dat bevat  
nog veel meer observaties, lessen en aanbevelingen.
264 265
I.	Voorzie	in	continuïteit	van	innovatiebeleid	voor		
15	jaar	of	langer	(p.	62-66)
Nederland heeft de ambitie een internationaal toonaan-
gevende kenniseconomie te worden en een prominente rol te 
spelen bij het aanpakken van maatschappelijke uitdagingen 
als klimaatverandering. Innovatie is daarvoor onontbeerlijk. 
In de life sciences vergt innovatie 15 jaar of meer: van eerste 
idee tot het omarmen van een nieuw product, proces of 
dienst door de maatschappij. Daarbij moet veel tijd, energie 
en geld worden geïnvesteerd bij onzekere uitkomsten.  
De Nederlandse overheid heeft goede instrumenten om 
innovatie te stimuleren, maar het beleid zelf verandert 
tenminste iedere vier jaar – in prioriteiten, criteria, instru-
menten, procedures en aanspreekpunten. Als de regels 
blijven veranderen tijdens het innovatiespel blijven rende-
menten op eerdere investeringen uit, nieuwe initiatieven 
liggen en onze ambities bij woorden. 
Om dit te veranderen moet het veld duidelijk uitdragen waar 
het heen wil en wat daarvoor nodig is. Dat is de bedoeling 
van Partners in the Polder. Hiermee kan de overheid lange 
termijndoelen (> 15 jaar) definiëren als leidraad voor 
innovatiebeleid en zo de regels grotendeels constant houden, 
laten aansluiten bij (inter)nationale “best practices” en op 
maat snijden voor de life sciences. De juiste (combinaties 
van) instrumenten kunnen dan in ieder stadium van 
innovatie worden ingezet en voortgang en resultaten 
voortdurend bewaakt. Op deze manier wordt publiek  
geld effectief en legitiem geïnvesteerd.
II.	Bouw	voort	op	de	sterkten	die	zijn	ontwikkeld		
(p.	67-75)
Alle belanghebbenden in de life sciences moeten voort- 
bouwen op de sterkten die tot stand zijn gebracht. De eerste 
prioriteit moet zijn de vruchten te plukken van eerdere 
investeringen door de beste condities te scheppen voor het 
gebruik en vermarkten van innovaties. Daartoe horen goede 
toegankelijkheid van kennis en patenten, ruime beschikbaar-
heid van (durf)kapitaal, vrijwaring van onnodig restrictieve 
regelgeving, goed geïnformeerde en kritische burgers en een 
goed functionerende markt. Het veld en de overheid moeten 
deze condities samen creëren. Partners in the Polder bevat  
vele tips en ideeën: van valorisatiemechanismen tot  
certificatiesystemen tot “launching customers”.
Nederland moet haar rijke (nationale) PPP landschap naar  
het volgende niveau van schaal en bereik tillen. Het veld zou 
de meer dan 40 Nederlandse PPPs waarin de life sciences een 
rol spelen moeten consolideren tot tien of minder clusters die 
deel uitmaken van internationale netwerken. De overheid  
zou moeten blijven investeren in dergelijke partnerschappen. 
Ook zou de overheid meer moeten investeren in fundamen-
teel onderzoek door academici om onze internationaal 
leidende kennispositie te behouden (juist in economisch 
moeilijke tijden). Universiteiten hebben de verantwoordelijk-
heid om onderzoeksresultaten te valoriseren en het makkelijk 
te maken voor ondernemers om toegang te krijgen tot kennis 
en patenten en die te gebruiken. Ook onderwijs is een 
prioriteit. Innovatie in de life sciences vraagt zowel om 
goedopgeleide onderzoekers, ondernemers en investeerders  
als om welingelichte burgers die zelf kunnen besluiten een 
innovatie wel of niet te gebruiken.
III.	Positioneer	Nederland	als	één	bioregio	(p.	75-78)
In de Nederlandse life sciences zijn de afstanden klein. 
Internationaal leidende academische groepen en sterke 
industriesectoren (voeding, gezondheid, agricultuur en 
chemie & energie) zijn verenigd op een klein oppervlak. 
Door zich te positioneren als één bioregio met lokale 
zwaartepunten en te profiteren van de Nederlandse tradities 
van samenwerking en handel, kunnen de Nederlandse  
life sciences zeer concurrerend zijn en buitengewoon 
aantrekkelijk voor internationale partners.
Succesvol samenwerken wordt steeds meer een bron van 
concurrentievoordeel. Het life sciences veld zal de samen-
werking na dit boek doorzetten, ervaringen blijven delen en 
(informele) coördinatie opzetten waar nuttig. De PPPs van 
vandaag zullen toekomstige PPPs helpen hun voordeel te doen 
met de lessen die zijn geleerd en de ”back offices” die reeds 
bestaan. Kortom, de belanghebbenden bij de Nederlandse life 
sciences zullen steeds meer worden tot Partners in the Polder.
